Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A systematic pan-cancer analysis of PXDN as a potential target for clinical diagnosis and treatment

2 Aug 2022

Abstract excerpt

Peroxidasin (PXDN), also known as vascular peroxidase-1, is a newly discovered heme-containing peroxidase; it is involved in the formation of extracellular mesenchyme, and it catalyzes various substrate oxidation reactions in humans. However, the role and specific mechanism of PXDN in tumor are unclear, and no systematic pan-cancer studies on PXDN have been reported to date. This study employed data from multiple...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer Immunotherapy and Biomarkers
Share to Neutrophil, Myeloperoxidase and Oxidative Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35982948
DOI: 10.3389/fonc.2022.952849

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A systematic pan-cancer analysis of PXDN as a potential target for clinical diagnosis and treatmentPMID 35982948Read ↗

The oncogenic role and prognostic value of PXDN in human stomach adenocarcinomaSemantic proximity Read ↗

Pan-cancer analysis reveals the value of FDX1 as a novel biomarker in the prognosis and immunotherapy in human tumorsSemantic proximity Read ↗

PXDN as a pan-cancer biomarker and promotes tumor progress via immune inhibition in nasopharyngeal carcinomaSemantic proximity Read ↗

Pan-Cancer Analysis of the Role of the Ferroptosis-Related Biomarker GPX4: A Potential Target for Prognosis and ImmunotherapySemantic proximity Read ↗

Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysisSemantic proximity Read ↗

Integrative analysis the characterization of peroxiredoxins in pan-cancerSemantic proximity Read ↗

A Pan-cancer Analysis of Thioredoxin-interacting Protein as an Immunological and Prognostic BiomarkerSemantic proximity Read ↗

A pan-cancer analysis of thioredoxin-interacting protein as an immunological and prognostic biomarkerSemantic proximity Read ↗

Glutathione peroxidase 3 (GPX3) expression predicts the prognosis of numerous malignant tumors: A pan-cancer AnalysisSemantic proximity Read ↗

Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancerSemantic proximity Read ↗

Prognostic and immunological role of FDX1 in pan-cancer: an in-silico analysisSemantic proximity Read ↗

Prognostic and immunological value of Chromobox family genes in Pan-CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.